跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 17,094 条关于
“Otsuka Pharmaceutical Europe”
全部
17,094
临床试验
1,412
药物
1,706
机构
2,351
资讯
11,625
去年
European Commission Approves Rxulti for Adolescent Schizophrenia Treatment
去年
Otsuka Pharmaceutical Acquires Cantargia's CAN10 Antibody Program for $33 Million Upfront in Autoimmune Disease Deal
去年
Otsuka Pharmaceutical Secures Global Rights to HBM7020 BCMAxCD3 Bispecific T-Cell Engager for Autoimmune Diseases
7个月前
Otsuka Pharmaceutical Secures Exclusive Rights to Sky Labs' Cuffless Blood Pressure Monitor for Japan Market
去年
Otsuka Pharmaceutical Challenges Vera Therapeutics in Kidney Disease Race as GLP-1 Drugs Face Eye Safety Scrutiny
去年
Astellas Withdraws European Application for Avacincaptad Pegol in Geographic Atrophy
去年
Otsuka Receives Japanese Approval for NEXLETOL as Novel Non-Statin Cholesterol Treatment
10个月前
4DMT Secures $85 Million Upfront in Strategic Partnership with Otsuka for Gene Therapy 4D-150 in Asia-Pacific
去年
Otsuka's Sibeprenlimab Shows Positive Phase 3 Interim Results for IgA Nephropathy
9个月前
Otsuka Submits FDA Application for First-in-Class ADHD Drug Centanafadine
第 1 页，共 1163 页
上一页
下一页
